Lieberman Laboratory

The Lieberman Laboratory studies cytotoxic T lymphocytes (CTL) that are key cells in the immune defense against viral infection and cancer.

Please visit the Lieberman Laboratory for more information.

Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer

© 2005-2021 All Rights Reserved